Incyte Corporation (BIT:1INCY)
87.24
+1.08 (1.25%)
At close: Dec 5, 2025
Revenue
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| JAKAFI Product Revenue | 3.04B | 2.79B |
Log In |
Log In |
Log In | Upgrade
|
| OPZELURA Product Revenue | 632.77M | 508.29M |
Log In |
Log In |
Log In | Upgrade
|
| ICLUSIG Product Revenue | 127.22M | 114.32M |
Log In |
Log In |
Log In | Upgrade
|
| PEMAZYRE Product Revenue | 86.52M | 81.75M |
Log In |
Log In |
Log In | Upgrade
|
| MINJUVI Product Revenue | 135.48M | 119.24M |
Log In |
Log In |
Log In | Upgrade
|
| ZYNYZ Product Revenue | 35.98M | 3.19M |
Log In |
Log In |
Log In | Upgrade
|
| Total Product Revenue | 4.15B | 3.62B |
Log In |
Log In |
Log In | Upgrade
|
| JAKAVI Royalty Revenue | 441.69M | 418.84M |
Log In |
Log In |
Log In | Upgrade
|
| OLUMIANT Royalty Revenue | 139.88M | 135.57M |
Log In |
Log In |
Log In | Upgrade
|
| TABRECTA Royalty Revenue | 25.84M | 22.75M |
Log In |
Log In |
Log In | Upgrade
|
| Other Royalty Revenue | 4.74M | 2.17M |
Log In |
Log In |
Log In | Upgrade
|
| Total Royalty Revenue | 612.15M | 579.33M |
Log In |
Log In |
Log In | Upgrade
|
| Milestone and Contract Revenue | - | 43.00M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | 14.02M | -3.19M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 4.81B | 4.24B |
Log In |
Log In |
Log In | Upgrade
|